A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to understand the feasibility of a text messaging
intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve
smoking cessation among opiate and/or alcohol dependent participants discharged from an
inpatient detoxification unit and enrolled in an office-based buprenorphine program patients
(OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of
informational pamphlets and information for a 1800 quit line; and a prescription for a
nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity
of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which
is offered routinely to all inpatients at Bellevue at the time of discharge) versus the
SmokeFreeTXT intervention plus prescriptions for NRT.
Phase:
N/A
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health